Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2025-12-24 @ 10:45 PM
NCT ID: NCT06679335
Eligibility Criteria: Inclusion Criteria: * Inclusion criteria * Between the ages of 18-65, having neck pain lasting more than 3 months, * Speaks and understands the Turkish language at a sufficient level, * Able to use telephone and computer, * Being literate, * Scored 21 or more on the Montreal Cognitive Assessment (MoCA) scale, which evaluates the cognitive status of individuals, * Reporting pain intensity as 30 mm or more on the Visual Analogue Scale (VAS), * Individuals with level 3 according to the Neck Pain Task Force Scale will be included. Inclusion criteria for healthy group / Asymptomatic Individuals * Asymptomatic between the ages of 18-65, * Individuals matched with the study group in terms of body mass index and age * Do not feel neck or back pain that prevents them from normal activities, * Those who have not previously received medical intervention or treatment for their neck problem, * Being literate, * Individuals who score 21 or above on the Montreal Cognitive Assessment (MoCA) scale, which evaluates the cognitive status of individuals, will be included. Exclusion criteria * Have received physiotherapy treatment due to neck pain in the last 6 months, * Those who have had neck surgery, * Suspicion of malignant or systemic disease, * Having a neurological disease or injury, * Individuals with vertigo, nausea, visual disturbances will not be included.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT06679335
Study Brief:
Protocol Section: NCT06679335